FDA Approves Viridian’s Thyroid Eye Disease Drug, Competitor to a Blockbuster Amgen MedNews DeskJune 28, 20260 A Viridian Therapeutics drug for thyroid eye disease now has FDA approval, making it just the second therapy for this…
A Metabolic Disease Posing Severe Pancreatic Risks Gets Its First FDA-Approved TherapyNews DeskJune 26, 20260 A metabolic disorder that leads to high levels of fat in the blood and life-threatening pancreatic complications now has its…
Real-Time Trials Are Here — Now We Need Real-Time TrustNews DeskJune 25, 20260 Earlier this year, the FDA announced a breakthrough that could fundamentally transform how medical evidence reaches patients. For the first…
New FDA Nod Keeps Gilead Drug Competitive With AstraZeneca & Daiichi in Breast CancerNews DeskJune 25, 20260 The FDA has expanded the approval of a targeted Gilead Sciences therapy as a new first-line treatment for triple-negative breast…